ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moyana, T.
Right arrow Articles by Janoski, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moyana, T.
Right arrow Articles by Janoski, M
Annals of Clinical and Laboratory Science, Vol 26, Issue 6, 480-486
Copyright © 1996 by Association of Clinical Scientists


Articles

Recent trends in the epidemiology of esophageal cancer. Comparison of epidermoid- and adenocarcinomas

TN Moyana and M Janoski

This was a retrospective study of 306 consecutive patients with esophageal carcinoma seen at the Saskatoon Cancer Center from 1970 to 1992, making an annual incidence of approximately 2.7 percent per 100,000 population. The two main cancer types were (1) epidermoid carcinoma (199 patients or 69 percent), and (2) adenocarcinoma (81 patients or 28 percent). At the time of diagnosis, all patients had advanced disease with > 60 percent having extra-esophageal spread. Patient management was conventional with radiotherapy, surgery, chemotherapy, or combinations thereof being the mainstay of treatment. After a mean follow-up of 13 months, 82 percent of the patients had died of disease, 11 percent of other causes, and none were cured of disease. An analysis of the time trends showed an increasing incidence of both epidermoid carcinomas and adenocarcinomas, particularly the latter. There was a preponderance of distally located tumors in either group. The reasons for these trends in the pathobiology of esophageal carcinoma are not fully understood at this time.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J.-M. Lee, M.-T. Wu, Y.-C. Lee, S.-Y. Yang, J.-S. Chen, H.-H. Hsu, P.-M. Huang, S.-W. Kuo, C.-J. Lee, and C.-J. Chen
Association of GSTP1 Polymorphism and Survival for Esophageal Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4749 - 4753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association of Clinical Scientists.